Crossmark

Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials

Crossref DOI link: https://doi.org/10.1007/s40120-019-0146-z

Published Online: 2019-07-19

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghezzi, Angelo

Chitnis, Tanuja

K-Laflamme, Annik

Meinert, Rolf

Häring, Dieter A.

Pohl, Daniela
Funding

Funding for this research was provided by:

Novartis Pharma AG
License Information

Text and Data Mining valid from 2019-07-19

Version of Record valid from 2019-07-19
More Information

Article History

Received: 3 June 2019

First Online: 19 July 2019

Change Date: 14 February 2020

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40120-020-00178-4

Updates are available Correction dated 2020-02-14

Click to view Correction: https://doi.org/10.1007/s40120-020-00178-4